Aurinia Announces Management Transition

2026-03-23 - 12:10

ROCKVILLE, Maryland & EDMONTON, Alberta -- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) announced today that Kevin Tang, Aurinia’s Chair of the Board, will succeed Peter Greenleaf as Chief Executive Officer. Peter will continue as a consultant to facilitate the transition. Read More